Huang L, Zinselmeyer B, Chang C, Saunders B, Elvington A, Baba O, et al. Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis. Cell Metab. 2019;29:475-487.e7 pubmed publisher

Romano G, Reggi S, Kutryb Zajac B, Facoetti A, Chisci E, Pettinato M, et al. APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe-/- atherosclerotic mice. Int J Cardiol. 2018;271:233-239 pubmed publisher

Xie Z, Wang X, Liu X, Du H, Sun C, Shao X, et al. Adipose-Derived Exosomes Exert Proatherogenic Effects by Regulating Macrophage Foam Cell Formation and Polarization. J Am Heart Assoc. 2018;7: pubmed publisher

Croca S, Bassett P, Chambers S, Davari M, Alber K, Leach O, et al. IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. Arthritis Res Ther. 2015;17:26 pubmed publisher

Yue P, Chen Z, Nassir F, Bernal Mizrachi C, Finck B, Azhar S, et al. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice. PLoS ONE. 2010;5:e9906 pubmed publisher

Henderson R, Wasan K, Leon C. Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma. Lipids Health Dis. 2009;8:27 pubmed publisher

Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem. 2005;280:7793-9 pubmed

Menzel H, Assmann G, Rall S, Weisgraber K, Mahley R. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. J Biol Chem. 1984;259:3070-6 pubmed